Lumateperone (ITI-007, CAPLYTA™) is an antipsychotic agent, discovered and developed by Intra-Cellular Therapies, Inc. (ITCI) and approved for treatment of schizophrenia in adults in December 2019. Lumateperone is available as Lumateperone tosylate.

More Raghava Choudary Palacharla's questions See All
Similar questions and discussions